Equity awards to Stepan (NYSE: SCL) VP in corrected Form 4

Rhea-AI Filing Summary

Stepan Company executive Sean Thomas Moriarty reported multiple equity awards and updated holdings. On March 2, 2026, he was granted 6,440 Stock Appreciation Rights, 2,247 performance shares, and 4,495 restricted stock units, each generally vesting ratably over three years beginning on that grant date.

The performance shares vest upon certification that Stepan Company meets performance goals for the period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock at $52.51 per share as an award, bringing his direct common stock holdings to 14,205.2335 shares and his indirect holdings via the ESOP II Trust to 4,478.351 shares. A prior Form 4 incorrectly stated the Stock Appreciation Right amount and is corrected in this amendment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moriarty Sean Thomas

(Last) (First) (Middle)

1101 SKOKIE BOULEVARD, SUITE 500

(Street)

NORTHBROOK IL 60062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STEPAN CO [ SCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP & GM Surfactants

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		56.765	A	$52.51	14,205.2335	D
Common Stock								4,478.351	I	By ESOP II Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	$17.47	03/02/2026		A		6,440		03/02/2027(1)	03/03/2036	Common Stock	6,440(2)	$0	6,440	D
Performance Shares	(3)	03/02/2026		A		2,247		(4)	(4)	Common Stock	2,247	$0	2,247	D
Restricted Stock Units	(5)	03/02/2026		A		4,495		03/02/2027(1)	03/02/2029	Restricted Stock Units	4,495	$0	4,495	D

Explanation of Responses:

1. Vest ratably over three years beginning on the date shown.

2. The Reporting Person's Form 4 filed on March 4, 2026 included an incorrect Stock Appreciation Right amount which has been corrected herein.

3. Each performance share represents a contingent right to receive one share of Stepan Company common stock.

4. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.

5. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.

	/s/ James A. Hart, Attorney-in-Fact for Sean T. Moriarty	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Stepan (SCL) grant to Sean Thomas Moriarty?

Sean Thomas Moriarty received multiple equity awards. On March 2, 2026, he was granted 6,440 Stock Appreciation Rights, 2,247 performance shares, and 4,495 restricted stock units, all tied to Stepan Company common stock and subject to stated vesting conditions.

How do the performance shares for Stepan (SCL) executive Sean Moriarty vest?

The performance shares vest based on long-term goals. Each performance share represents a right to one Stepan Company common share and vests when Stepan’s performance goals for the period ending December 31, 2028 are certified as achieved.

What are the vesting terms for Sean Moriarty’s Stepan (SCL) stock awards?

The stock awards generally vest over three years. The grant on March 2, 2026 of Stock Appreciation Rights, performance shares, and restricted stock units vests ratably over three years beginning on that grant date, subject to the specific plan conditions.

How many Stepan (SCL) common shares does Sean Moriarty hold directly and indirectly?

Sean Moriarty holds both direct and indirect Stepan shares. After the reported February 27, 2026 award, he holds 14,205.2335 common shares directly and 4,478.351 common shares indirectly through the ESOP II Trust, according to the Form 4/A data.

What common stock transaction did Sean Moriarty report for Stepan (SCL)?

He reported an award of Stepan common stock. On February 27, 2026, he acquired 56.765 shares of Stepan Company common stock at a price of $52.51 per share as a grant or award acquisition.

Why did Stepan (SCL) file an amended Form 4/A for Sean Moriarty?

The amended Form 4/A corrects a prior error. A footnote states that the Form 4 filed on March 4, 2026 included an incorrect Stock Appreciation Right amount, which has been corrected in this amended filing.